Skip to main content

Advertisement

Log in

Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Prostate cancer (PCa) is the most common cancer among men. It has been suggested that toll like receptors (TLRs) may contribute to PCa pathogenesis by stimulating prostate epithelial cell proliferation in response to infectious stimuli. We performed case control study to analyze the genetic variants of TLR2, 3 and 9 gene polymorphisms with PCa risk in a North Indian population. For this study we genotyped age matched, unrelated 195 PCa patients and 250 healthy controls of similar ethnicity in a case–control study. They were genotyped for TLR2 (−196 to −174 Del), TLR3 (c.1377C/T) [rs3775290] and TLR9 (G2848A) [rs352140] gene polymorphisms using polymerase chain reaction and restriction fragment length polymorphism method. Variant allele Del (D) carriers i.e. (ID + DD) of TLR2 (−196 to −174 Del) SNP, demonstrated 1.57 fold increased risk (p = 0.040; OR = 1.57, 95% CI = 1.02–2.24) as compared to Ins (I) allele, suggesting a dominant effect model involved in the risk of this polymorphism in PCa. However, variants of TLR3 and 9 gene polymorphisms were not associated with PCa risk. Our results suggested the low penetrance variant of TLR2 (−196 to −174 Del) to be at increased PCa risk in North Indian population. Functional studies in ethnically diverse populations may provide a more comprehensive involvement of innate immunity in identifying the disease-associated variants for PCa etiology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 5:277–300

    Article  Google Scholar 

  2. Sinha R, Anderson DE, McDonald SS, Greenwald P (2003) Cancer risk and diet in India. J Postgrad Med 49:222–228

    PubMed  CAS  Google Scholar 

  3. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M et al (2000) Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85

    Article  PubMed  CAS  Google Scholar 

  4. Tanner MA, Shoskes D, Shahed A, Pace NR (1999) Prevalence of corynebacterial 16S rRNA sequences in patients with bacterial and “nonbacterial” prostatitis. J Clin Microbiol 37:1863–1870

    PubMed  CAS  Google Scholar 

  5. Boldogh I, Baskar JF, Mar EC, Huang ES (1983) Human cytomegalovirus and herpes simplex type 2 virus in normal and adenocarcinomatous prostate glands. J Natl Cancer Inst 70:819–826

    PubMed  CAS  Google Scholar 

  6. Serth J, Panitz F, Paeslack U, Kuczyk MA, Jonas U (1999) Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. Cancer Res 59:823–825

    PubMed  CAS  Google Scholar 

  7. Aderem A, Ulevitch RJ (2000) Toll-like receptors in the induction of the innate immune response. Nature 406:782–787

    Article  PubMed  CAS  Google Scholar 

  8. Cheng I, Plummer SJ, Casey G, Witte JS (2007) Toll-like receptor 4 genetic variation and advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev 16:352–355

    Article  PubMed  CAS  Google Scholar 

  9. Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ (2005) Sequence variants of toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res 65:11771–11778

    Article  PubMed  CAS  Google Scholar 

  10. Kundu SD, Lee C, Billips BK, Habermacher GM, Zhang Q, Liu V et al (2008) The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate 68:223–229

    Article  PubMed  CAS  Google Scholar 

  11. Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1:135–145

    Article  PubMed  CAS  Google Scholar 

  12. Pandey S, Agrawal DK (2006) Immunobiology of toll-like receptors: emerging trends. Immunol Cell Biol 84:333–341

    Article  PubMed  CAS  Google Scholar 

  13. El Omar EM, Ng MT, Hold GI (2008) Polymorphisms in toll like receptor genes and risk of Cancer. Oncogene 27:244–252

    Article  PubMed  Google Scholar 

  14. Schroder NW, Schumann RR (2005) Single nucleotide polymorphisms of toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 5:156–164

    PubMed  Google Scholar 

  15. Gleason DF, Mellinger GT (1974) Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111:58–64

    PubMed  CAS  Google Scholar 

  16. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215

    Article  PubMed  CAS  Google Scholar 

  17. Tahara T, Arisawa T, Wang F, Shibata T, Nakamura M, Sakata M et al (2007) Toll-like receptor 2—196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer. Cancer Sci 98:1790–17904

    Article  PubMed  CAS  Google Scholar 

  18. Pandey S, Mittal B, Srivastava M, Singh S, Srivastava K, Lal P et al (2010) Evaluation of toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility. Mol Biol Rep 38:4715–4721

    Article  PubMed  Google Scholar 

  19. Le Bon A, Tough DF (2002) Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 14:432–436

    Article  PubMed  Google Scholar 

  20. Platz EA, De Marzo AM (2004) Epidemiology of inflammation and prostate cancer. J Urol 271:36–40

    Article  Google Scholar 

  21. Srivastava K, Srivastava A, Kumar A, Mittal B (2010) Significant association between toll-like receptor gene polymorphisms and gallbladder cancer. Liver Int 30:1067–1072

    Article  PubMed  CAS  Google Scholar 

  22. Noguchi E, Nishimura F, Fukai H, Kim J, Ichikawa K, Shibasaki M et al (2004) An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy 34:177–183

    Article  PubMed  CAS  Google Scholar 

  23. He JF, Jia WH, Fan Q, Zhou XX, Qin HD, Shugart YY et al (2007) Genetic polymorphisms of TLR3 are associated with Nasopharyngeal carcinoma risk in Cantonese population. BMC Cancer 7:194

    Article  PubMed  Google Scholar 

  24. Etokebe GE, Knezević J, Petricević B, Pavelić J, Vrbanec D, Dembić Z (2009) Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in case-control study with breast cancer. Genet Test Mol Biomarkers 13:729–734

    Article  PubMed  CAS  Google Scholar 

  25. Hold GL, Rabkin CS, Gammon MD, Berry SH, Smith MG, Lissowska J et al (2009) CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations. Eur J Cancer Prev 18:117–119

    Article  PubMed  CAS  Google Scholar 

  26. Mollaki V, Georgiadis T, Tassidou A, Ioannou M, Daniil Z, Koutsokera A et al (2009) Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin’s lymphoma: a candidate-gene association study. J Hum Genet 54:655–659

    Article  PubMed  CAS  Google Scholar 

  27. Tsan MF (2006) Toll-like receptors, inflammation, and cancer. Semin Cancer Biol 16:32–37

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by Uttar Pradesh Council of Science and Technology (UPCST) Grant (CST/SERPD/D-1887/2008), Lucknow, India. The author RK Mandal is thankful to Council of Scientific and Industrial Research, New Delhi, India for providing Senior Research fellowship during the course of study. The authors are thankful to the urologists in the department of urology for providing the details of the clinical samples.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rama D. Mittal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mandal, R.K., George, G.P. & Mittal, R.D. Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population. Mol Biol Rep 39, 7263–7269 (2012). https://doi.org/10.1007/s11033-012-1556-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-012-1556-5

Keywords

Navigation